# Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery

> **NCT03431480** · PHASE1 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome
- Heart Defects, Congenital
- Pediatric Disorder

## Interventions

- **BIOLOGICAL:** Autologous Human Placental Cord Blood Mononuclear Cells

## Key facts

- **NCT ID:** NCT03431480
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2021-11-01
- **Final completion:** 2022-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431480, "Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03431480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*